The Huberman Lab
The Huberman Lab

Vaping, Alcohol Use & Other Risky Youth Behaviors | Dr. Bonnie Halpern-Felsher

In this episode, my guest is Dr. Bonnie Halpern-Felsher, PhD, FSAHM. She is a professor of pediatrics and adolescent medicine and a developmental psychologist at Stanford University School of Medicine. Dr. Halpern-Felsher is a world expert in adolescent decision-making and risk-taking behaviors. She

Featured Speakers

Scicomm Media Host

Topics Discussed

Episode Summary

Executive Summary: Andrew Huberman and Dr. Bonnie Halpern-Felsher discuss adolescent development and why teens are especially vulnerable to nicotine, cannabis, social-media-driven marketing, and other risky behaviors. They emphasize that conflict, poor monitoring, and targeted advertising matter more than family structure alone, and argue that effective prevention requires honest, ongoing conversations, harm-reduction tools, and youth-centered messaging that respects teen autonomy and defiance.

Main Topics: Adolescent development and autonomy (Priority: 5/5): Adolescence is framed as a period of rapid physical, emotional, and social change, with teens seeking autonomy while still needing parental monitoring and support. Family environment, conflict, and monitoring (Priority: 5/5): The discussion distinguishes divorce itself from conflict, stressing that parenting quality, supervision, and awareness of discretionary hours are key predictors of risk. Nicotine, vaping, and e-cigarette marketing (Priority: 5/5): The episode details how flavored, discreet, youth-targeted nicotine products and high-dose salt nicotine have driven teen use and addiction. Cannabis potency and psychosis risk (Priority: 4/5): They discuss rising THC potency, vaping/cannabis co-use, and evidence suggesting high-THC cannabis may trigger psychosis in vulnerable youth. Social media, peer influence, and marketing (Priority: 4/5): Smartphones and social platforms amplify bullying, viral embarrassment, and direct marketing, while also enabling peer-to-peer normalization of risky behavior. Prevention, cessation, and harm reduction (Priority: 5/5): The speakers argue that 'just say no' is ineffective; better approaches include comprehensive education, refusal skills, replacement behaviors, and practical harm reduction such as Narcan and test strips. Other risky behaviors: alcohol, driving, sex, and polysubstance use (Priority: 4/5): The conversation broadens to drunk driving, delayed driving, sexual behavior, and co-use of multiple substances, noting that teens often mix drugs and self-medicate stress.

Key Arguments: Adolescence is a normal but high-risk developmental stage because teens are biologically and socially primed for exploration, autonomy, and peer influence. Divorce itself is not the main issue; conflict, poor parenting, and lack of monitoring are more strongly linked to teen distress and risk-taking. Smartphones are not universally harmful, but they intensify bullying, viral humiliation, and youth-targeted marketing, especially for nicotine and cannabis. Teen nicotine initiation is driven by flavors, concealability, social use, stress coping, and aggressive marketing—not by school-related cognitive enhancement. Salt-based nicotine and high-nicotine pods make e-cigarettes smoother, easier to use, and more addictive, accelerating dependence in youth. Nicotine harms the developing brain and can rapidly produce withdrawal and addiction; many teens use soon after waking, a classic addiction marker. Cannabis potency has increased substantially, and high-THC products may contribute to psychosis in predisposed adolescents and young adults. Effective prevention requires conversations that connect behavior to teen goals, identity, environment, and industry manipulation rather than fear-based lectures. Harm reduction is necessary because many teens are already using; practical safety tools can reduce death and injury even if abstinence is the goal. Youth are not passive victims: many are already resisting vaping, organizing against drug use, and responding to messages about environment, autonomy, and being manipulated by industry.

Data Points: Adolescence age range: ~10 to 18/21, with young adulthood extending into the mid-20s - Definition of adolescence and related developmental window Teen cigarette smoking rate: Well below 10%, likely below 5% - Conventional cigarette smoking has declined dramatically among U.S. teens Teen e-cigarette use peak: 27% to 29% of teens - Past-30-day e-cigarette use during 2017-2019 High school e-cigarette increase: 78% increase - Rise in high school student use over the cited peak years Middle school e-cigarette increase: 48% increase - Rise in middle school student use over the cited peak years Current national teen e-cigarette use: Around 10% - Latest CDC-style national data discussed by the guest School-reported teen e-cigarette/cannabis use: 40% to 60% - Guest’s anecdotal reports from schools seeking prevention help Nicotine concentration in newer pods: ~59 mg/mL - Salt-based nicotine products introduced with Juul-style devices Nicotine equivalence per pod/device: About 1 to 2 packs of cigarettes; newer devices may equal 300 to 500 cigarettes worth of nicotine - Comparison of nicotine load in e-cigarette products Teen pod consumption: 1 pod/week to 1-4 pods/day - Reported use among highly addicted teens Teen cannabis use prevalence: 10% to 20% - Estimated teen use of smoked cannabis or blunts THC potency in dabbing: About 80% THC - Compared with mainstream cannabis products at roughly 20% to 30% THC Blunt composition: Tobacco + cannabis - Explained as cigar leaf or emptied cigar filled with cannabis Nicotine pouch prevalence: About 11% to 15% of teens in one study; 1.1% to 1.5% in CDC-style surveillance for pouches generally - Use of Zyn-like nicotine pouches among youth Nicotine pouch dose: 3 mg or 6 mg per pouch - Typical Zyn pouch strengths discussed Age of legal nicotine purchase in U.S.: 21 - Federal age restriction since December 2019 Brain development completion: Around age 25 - Nicotine and cannabis are especially concerning during ongoing brain development Cannabis addiction risk in youth: About 1 in 6 - Addiction risk under age 25 Teen use after waking: Within the first 5 minutes - Marker of nicotine addiction in e-cigarette-using teens Smoking cessation attempts: 7 to 11 tries - Typical number of quit attempts before success for smokers Psychosis prevalence: About 1% of the world population - Used to underscore the public-health significance of cannabis-associated psychosis risk

Pivotal Quotes: "The problem comes in whether parents are living at home together or separated or divorced is if there's conflict." — Dr. Bonnie Halpern-Felsher: On why family conflict matters more than divorce status itself "Just say no does not work." — Dr. Bonnie Halpern-Felsher: On why fear-based, abstinence-only messaging fails with teens "They're being targeted." — Dr. Bonnie Halpern-Felsher: On youth-directed nicotine and cannabis marketing and the need to expose industry manipulation

Implications: Prevention should shift from scare tactics to honest, youth-centered conversations, stronger regulation, and practical harm reduction. Parents, schools, and clinicians should address nicotine/cannabis use early, normalize discussion, and help teens build healthier identities and peer groups.

🔓 Sign Up for Unlimited Episode Search

About The Huberman Lab

The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

View all episodes from The Huberman Lab